Who are in the management team of Amicus Therapeutics, Inc.?

Jun 22 2025 10:33 PM IST
share
Share Via
As of March 2022, the management team of Amicus Therapeutics, Inc. includes Chairman and CEO John Crowley, President and COO Bradley Campbell, and several independent directors: Michael Raab, Lynn Bleil, Robert Essner, Michael Kelly, and Margaret McGlynn.
As of March 2022, the management team of Amicus Therapeutics, Inc. includes the following individuals:

- Mr. John Crowley, who serves as the Chairman of the Board and Chief Executive Officer.
- Mr. Bradley Campbell, who is the President, Chief Operating Officer, and a Director.
- Mr. Michael Raab, who holds the position of Lead Independent Director.
- Ms. Lynn Bleil, who is an Independent Director.
- Mr. Robert Essner, who is also an Independent Director.
- Mr. Michael Kelly, who serves as an Independent Director.
- Ms. Margaret McGlynn, who is an Independent Director.

In summary, the management team consists of a mix of executive leadership and independent directors, with Mr. Crowley and Mr. Campbell in key operational roles.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News